ReviewCurrent obesity reports2026

The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation.

Christo Albor et al.PubMed ↗Publisher ↗

No numbers read from the abstract.